id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0233-0191,FDA,FDA-2002-N-0233,"Meeting between FDA and California Fine Wine Alliance, & Congressman Henry Bonilla's Office",Other,MM-Memorandum of Meeting,2004-10-05T04:00:00Z,2004,10,,,2009-03-25T15:15:27Z,,0,0,0900006480498f4f
FDA-2002-N-0233-0182,FDA,FDA-2002-N-0233,List of FDA Domestic Outreach Meetings,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:41Z,,0,0,0900006480498f2c
FDA-2002-N-0233-0180,FDA,FDA-2002-N-0233,Bioterrorism Act Seminar Attendance Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:48Z,,0,0,0900006480498f27
FDA-2002-N-0233-0185,FDA,FDA-2002-N-0233,"Meeting held in El Paso, Texas on March 9, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:28Z,,0,0,0900006480498f34
FDA-2002-N-0233-0186,FDA,FDA-2002-N-0233,"Meeting held in Salt Lake City, Utah on March 11, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:33Z,,0,0,0900006480498f37
FDA-2002-N-0233-0188,FDA,FDA-2002-N-0233,"Meeting held in New Orleans, Louisiana on March 18, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:28Z,,0,0,0900006480498f3e
FDA-2002-N-0233-0183,FDA,FDA-2002-N-0233,"Meeting held in Denver, Colorado on March 2, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:22Z,,0,0,0900006480498f2f
FDA-2002-N-0233-0187,FDA,FDA-2002-N-0233,"Meeting held in Kansas City, Missouri on March 16, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:22Z,,0,0,0900006480498f3a
FDA-2002-N-0233-0189,FDA,FDA-2002-N-0233,"Meeting held in Philadelphia, Pennsylvania on March 24, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:36Z,,0,0,0900006480498f40
FDA-2002-N-0233-0179,FDA,FDA-2002-N-0233,Downlink Attendence Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:28Z,,0,0,0900006480498f24
FDA-2002-N-0233-0181,FDA,FDA-2002-N-0233,Bioterrorism Act Seminar Attendance Sheet,Other,LST-List,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:28Z,,0,0,0900006480498f29
FDA-2002-N-0233-0184,FDA,FDA-2002-N-0233,"Meeting held in Fresno, California on March 4, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:36Z,,0,0,0900006480498f31
FDA-2002-N-0233-0190,FDA,FDA-2002-N-0233,"Meeting held in Boston, Massachusetts on April 1, 2004",Other,TR-Transcript,2004-07-30T04:00:00Z,2004,7,,,2008-04-12T01:23:33Z,,0,0,0900006480498f44
FDA-2002-N-0233-0172,FDA,FDA-2002-N-0233,"Meeting Between FDA and CBP,CFIA and Canadian Boeder Services Agency",Other,MM-Memorandum of Meeting,2004-07-12T04:00:00Z,2004,7,,,2008-04-12T01:23:31Z,,0,0,0900006480498e3e
FDA-2002-N-0233-0173,FDA,FDA-2002-N-0233,"Meeting Between FDA and CBP,CFIA and Canadian Boeder Services Agency",Other,MM-Memorandum of Meeting,2004-07-12T04:00:00Z,2004,7,,,2008-04-12T01:23:21Z,,0,0,0900006480498e3f
FDA-2002-N-0233-0161,FDA,FDA-2002-N-0233,FDA,Notice,NEC-Notice of Extension,2004-05-19T04:00:00Z,2004,5,2004-05-13T04:00:00Z,2004-07-14T03:59:59Z,2008-04-12T01:23:33Z,,0,0,0900006480498cb6
FDA-2002-N-0233-0146,FDA,FDA-2002-N-0233,Joint FDA-CBP Plan,Supporting & Related Material,BKG-Background Material,2004-04-16T04:00:00Z,2004,4,,,2008-04-12T01:23:14Z,,0,0,0900006480498af0
FDA-2002-N-0233-0144,FDA,FDA-2002-N-0233,Joint FDA-CBP Plan,Supporting & Related Material,BKG-Background Material,2004-04-16T04:00:00Z,2004,4,,,2008-04-12T01:23:37Z,,0,0,0900006480498aec
FDA-2002-N-0233-0145,FDA,FDA-2002-N-0233,Joint FDA-CBP Plan,Supporting & Related Material,BKG-Background Material,2004-04-16T04:00:00Z,2004,4,,,2008-04-12T01:23:29Z,,0,0,0900006480498aee
FDA-2002-N-0233-0147,FDA,FDA-2002-N-0233,FDA,Notice,NAD-Notice of Availability of Data,2004-04-16T04:00:00Z,2004,4,2004-04-09T04:00:00Z,2004-05-15T03:59:59Z,2008-04-12T01:23:46Z,,0,0,0900006480498af2
FDA-2002-N-0233-0148,FDA,FDA-2002-N-0233,FDA,Notice,NEC-Notice of Extension,2004-04-16T04:00:00Z,2004,4,2004-04-09T04:00:00Z,2004-05-15T03:59:59Z,2008-04-12T01:23:37Z,,0,0,0900006480498af4
FDA-2002-N-0233-0139,FDA,FDA-2002-N-0233,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:23:29Z,,0,0,0900006480498ab7
FDA-2002-N-0233-0138,FDA,FDA-2002-N-0233,"New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules (Detroit, MI - 11/12/03) - Transcript",Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2009-08-05T15:35:43Z,,0,0,0900006480498ab2
FDA-2002-N-0233-0140,FDA,FDA-2002-N-0233,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:23:37Z,,0,0,0900006480498aba
FDA-2002-N-0233-0142,FDA,FDA-2002-N-0233,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:23:37Z,,0,0,0900006480498ac5
FDA-2002-N-0233-0141,FDA,FDA-2002-N-0233,New FDA Bioterrorism Act Registration and Prior Notice Interim Final Rules,Other,TR-Transcript,2004-03-01T05:00:00Z,2004,3,,,2008-04-12T01:23:37Z,,0,0,0900006480498abd
FDA-2002-N-0233-0137,FDA,FDA-2002-N-0233,FDA,Notice,NCR-Notice of Correction,2004-02-24T05:00:00Z,2004,2,2004-02-23T05:00:00Z,,2008-04-12T01:23:45Z,,0,0,0900006480498aad
FDA-2002-N-0233-0123,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:19:44Z,,0,0,0900006480498a71
FDA-2002-N-0233-0132,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:23:23Z,,0,0,0900006480498a99
FDA-2002-N-0233-0126,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:21:17Z,,0,0,0900006480498a7e
FDA-2002-N-0233-0128,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:22:15Z,,0,0,0900006480498a88
FDA-2002-N-0233-0134,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:27:18Z,,0,0,0900006480498aa3
FDA-2002-N-0233-0125,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:20:59Z,,0,0,0900006480498a79
FDA-2002-N-0233-0131,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:23:09Z,,0,0,0900006480498a94
FDA-2002-N-0233-0127,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:21:49Z,,0,0,0900006480498a85
FDA-2002-N-0233-0130,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:22:53Z,,0,0,0900006480498a90
FDA-2002-N-0233-0133,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:28:05Z,,0,0,0900006480498a9c
FDA-2002-N-0233-0135,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:28:43Z,,0,0,0900006480498aa6
FDA-2002-N-0233-0122,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:20:22Z,,0,0,0900006480498a6c
FDA-2002-N-0233-0129,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:22:34Z,,0,0,0900006480498a8c
FDA-2002-N-0233-0124,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:20:43Z,,0,0,0900006480498a76
FDA-2002-N-0233-0136,FDA,FDA-2002-N-0233,See FDA-2002-N-0233-0216,Supporting & Related Material,REF-Reference (internal unless indicated),2004-02-05T05:00:00Z,2004,2,,,2009-10-15T16:29:07Z,,0,0,0900006480498aa8
FDA-2002-N-0233-0121,FDA,FDA-2002-N-0233,FDA,Notice,NCR-Notice of Correction,2004-02-04T05:00:00Z,2004,2,2004-01-30T05:00:00Z,,2008-04-12T01:23:40Z,,0,0,0900006480498a6a
FDA-2002-N-0233-0115,FDA,FDA-2002-N-0233,FDA,Notice,NCR-Notice of Correction,2004-01-08T05:00:00Z,2004,1,2004-01-06T05:00:00Z,,2008-04-12T01:23:40Z,,0,0,0900006480498a45